Literature DB >> 1945744

Antibiotic concentrations in the groin wound after vascular prosthetic implantation.

A C Van Loenen1, H J Martens, A J Mackaay, J A Rauwerda, F C Bakker, G A Vos.   

Abstract

The kinetics of systemically and locally administered cefuroxime or ceftazidime in wound fluid were investigated in the period after vascular prosthetic implantation. Cefuroxime or ceftazidime was administered intravenously in patients. Simultaneously 250 mg ceftazidime or cefuroxime was added to preclotted blood. Locally administered antibiotics could not be detected in our samples. In groin fluid samples 24-48 h after the operation the average concentration of cefuroxime was 8.3 and of ceftazidime 5.0 mg/l. The decline of the concentration of cefuroxime or ceftazidime in groin fluid seems to be much slower than one would expect from the half-lives of the antibiotics. We conclude that cefuroxime and to a lesser extent ceftazidime are suitable as prophylactic agents in arterial reconstruction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945744     DOI: 10.1007/bf01957743

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  5 in total

1.  An experimental study of arterial replacement in the presence of bacterial infection.

Authors:  J H FOSTER; T BERZINS; H W SCOTT
Journal:  Surg Gynecol Obstet       Date:  1959-02

2.  The application of antibiotic bonding to the treatment of established vascular prosthetic infection.

Authors:  R S Greco; S Z Trooskin; A P Donetz; R A Harvey
Journal:  Arch Surg       Date:  1985-01

3.  The role of antibiotic bonding in the prevention of vascular prosthetic infections.

Authors:  R S Greco; R A Harvey
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

4.  Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography.

Authors:  M C Rouan; F Abadie; A Leclerc; F Juge
Journal:  J Chromatogr       Date:  1983-06-10

5.  Kinetics of cefuroxime in the groin wound after vascular prosthetic implantation.

Authors:  T S Sørensen; J Aabech; N P Utzon; B Bruun; J E Lorentzen
Journal:  J Vasc Surg       Date:  1988-08       Impact factor: 4.268

  5 in total
  1 in total

Review 1.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.